Citigroup
DTIL icon

Citigroup’s Precision BioSciences DTIL Stock Holding History

Citigroup’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.3K Buy
+12,972
New +$59.8K ﹤0.01% 4395
2025
Q3 		– Sell
-923
Closed -$3.88K – 6151
2025
Q2 		$3.88K Buy
+923
New +$4.55K ﹤0.01% 5308
2025
Q1 		– Sell
-13
Closed -$50 – 5675
2024
Q4 		$50 Buy
13
+12
+1,200% +$88 ﹤0.01% 5714
2024
Q3 		$9 Hold
1
– – ﹤0.01% 5622
2024
Q2 		$10 Hold
1
– – ﹤0.01% 5516
2024
Q1 		$14 Sell
1
-1,554
-100% -$19K ﹤0.01% 5554
2023
Q4 		$17K Hold
1,555
– – ﹤0.01% 5037
2023
Q3 		$15.9K Hold
1,555
– – ﹤0.01% 4452
2023
Q2 		$24.5K Hold
1,555
– – ﹤0.01% 4906
2023
Q1 		$35.2K Buy
+1,555
New +$51.2K ﹤0.01% 4360
2022
Q4 		– Sell
-33
Closed -$1K – 5812
2022
Q3 		$1K Sell
33
-120
-78% -$5.7K ﹤0.01% 5624
2022
Q2 		$7K Sell
153
-1,225
-89% -$71.9K ﹤0.01% 5489
2022
Q1 		$127K Sell
1,378
-4,625
-77% -$628K ﹤0.01% 4306
2021
Q4 		$1.33M Buy
6,003
+1,676
+39% +$468K ﹤0.01% 2966
2021
Q3 		$1.5M Sell
4,327
-3,502
-45% -$1.19M ﹤0.01% 2763
2021
Q2 		$2.94M Sell
7,829
-5,224
-40% -$1.57M ﹤0.01% 2363
2021
Q1 		$4.05M Buy
13,053
+11,900
+1,032% +$4.17M ﹤0.01% 1936
2020
Q4 		$289K Buy
1,153
+963
+507% +$236K ﹤0.01% 4697
2020
Q3 		$35K Sell
190
-379
-67% -$75.4K ﹤0.01% 5816
2020
Q2 		$142K Buy
569
+36
+7% +$7.88K ﹤0.01% 5286
2020
Q1 		$96K Buy
533
+104
+24% +$27.2K ﹤0.01% 5370
2019
Q4 		$179K Buy
429
+328
+325% +$103K ﹤0.01% 5275
2019
Q3 		$25K Sell
101
-97
-49% -$31.6K ﹤0.01% 6581
2019
Q2 		$79K Buy
198
+194
+4,850% +$78.1K ﹤0.01% 6077
2019
Q1 		$2K Buy
+4
New +$2.12K ﹤0.01% 7527

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citigroup's DTIL Position: Q1 2026 in Review

Citigroup opened a new position in Precision BioSciences (DTIL) in Q1 2026: 12,972 shares worth $71.3K. The stake represents ﹤0.01% of the portfolio and ranks #4395 among its holdings. This is a return to the name: Citigroup previously reported a position in DTIL as recently as Q2 2025.

Citigroup first reported a position in DTIL in Q1 2019 and has held it in 25 quarters since. The position peaked at $4.05M in Q1 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Citigroup held 12,972 shares of Precision BioSciences worth $71.3K as of Q1 2026.
  • Precision BioSciences was a new Citigroup position in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4395 holding.
  • Citigroup first reported a position in Precision BioSciences in Q1 2019 and has held it in 25 quarters since.
  • Citigroup's Precision BioSciences position peaked at $4.05M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.